Dopamine modulates excitability of basolateral amygdala neurons in vitro

Journal of Neurophysiology

Volumn 93, Issue 3, 2005, Pages 1598-1610

  Kröner, Sven ^a,c,d   Rosenkranz, J Amiel ^a,d,e   Grace, Anthony A ^a,b   Barrionuevo, German ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c CENTER FOR THE NEURAL BASIS OF COGNITION   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; DENDROTOXIN; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; IN VITRO STUDY; INHIBITORY POSTSYNAPTIC POTENTIAL; INNERVATION; INTERNEURON; MALE; NERVE CELL EXCITABILITY; NERVE CONDUCTION; NERVE PROJECTION; NEUROMODULATION; NONHUMAN; PATCH CLAMP; POSTSYNAPTIC MEMBRANE; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SENSORY NERVE; SPIKE;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2-AMINO-5-PHOSPHONOVALERATE; 4-AMINOPYRIDINE; 6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ACTION POTENTIALS; AMYGDALA; ANESTHETICS, LOCAL; ANIMALS; ANIMALS, NEWBORN; BENZAZEPINES; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; ELAPID VENOMS; EXCITATORY AMINO ACID ANTAGONISTS; MEMBRANE POTENTIALS; NEURAL INHIBITION; NEURONS; NEURONS, AFFERENT; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; QUINPIROLE; RATS; STAINING AND LABELING; SULPIRIDE; SYNAPTIC TRANSMISSION; TETRODOTOXIN;

EID: 14144254086     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00843.2004     Document Type: Article

References (66)

1. Aggleton JP. The Amygdala: A Functional Analysis. Oxford, UK: Oxford Univ. Press, 2000.
2. Asan E. Ultrastructural features of tyrosine-hydroxylase-immunoreactive afferents and their targets in the rat amygdala. Cell Tissue Res 288: 449-469, 1997.
3. Asan E. The catecholaminergic innervation of the rat amygdala. Adv Anat Embryol Cell Biol 142: 1-118, 1998.
4. Bashore TR, Rebec GV, and Groves PM. Alterations of spontaneous neuronal activity in the caudate-putamen, nucleus accumbens and amygdaloid complex of rats produced by D-amphetamine. Pharmacol Biochem Behav 8: 467-474, 1978.
5. Bekkers JM and Delaney AJ. Modulation of excitability by α-dendrotoxin-sensitive potassium channels in neocortical pyramidal neurons. J Neurosci 21: 6553-6560, 2001.
6. Ben-Ari Y and Kelly JS. Dopamine evoked inhibition of single cells of the feline putamen and basolateral amygdala. J Physiol 256: 1-21, 1976.
7. Bissiere S, Humeau Y, and Lüthi A. Dopamine gates LTP induction in lateral amygdala by suppressing feedforward inhibition. Nat Neurosci 6: 587-592, 2003.
8. Blair HT, Schafe GE, Bauer EP, Rodrigues SM, and LeDoux JE. Synaptic plasticity in the lateral amygdala: a cellular hypothesis of fear conditioning. Learn Mem 8: 229-242, 2001.
9. Borowski TB and Kokkinidis L. Contribution of ventral tegmental area dopamine neurons to expression of conditional fear: effects of electrical stimulation, excitotoxin lesions, and quinpirole infusion on potentiated startle in rats. Behav Neurosci 110: 1349-1364, 1996.
10. Bracci E, Centonze D, Bernardi G, and Calabresi P. Dopamine excites fast-spiking interneurons in the striatum. J Neurophysiol 87: 2190-2194, 2002.
11. Brinley-Reed M and McDonald AJ. Evidence that dopatninergic axons provide a dense innervation of specific neuronal subpopulations in the rat basolateral amygdala. Brain Res 850: 127-135, 1999.
12. Chance SA, Esiri MM, and Crow TJ. Amygdala volume in schizophrenia: post-mortem study and review of magnetic resonance imaging findings. Br J Psychiatry 180: 331-338, 2002.
13. Chen JC and Lang EJ. Inhibitory control of rat lateral amygdaloid projection cells. Neuroscience 121: 155-166, 2003.
14. + channels. Ann NY Acad Sci 868: 233-285, 1999.
15. Dong Y and White FJ. Dopamine D1-class receptors selectively modulate a slowly inactivating potassium current in rat medial prefrontal cortex pyramidal neurons. J Neurosci 23: 2686-2695, 2003.
16. Drevets WC. Neuroimaging abnormalities in the amygdala in mood disorders. Ann NY Acad Sci 985: 420-444, 2003.
17. Faber ES, Callister RJ, and Sah P. Morphological and electrophysiological properties of principal neurons in the rat lateral amygdala in vitro. J Neurophysiol 85: 714-723, 2001.
18. Faber ES and Sah P. Physiological role of calcium-activated potassium currents in the rat lateral amygdala. J Neurosci 11: 1618-1628, 2002.
19. Faber ES and Sah P. Opioids inhibit lateral amygdala pyramidal neurons by enhancing a dendritic potassium current. J Neurosci 24: 3031-3039, 2004.
20. Gorelova N, Seanians JK, and Yang CR. Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex. J Neurophysiol 88: 3150-3166, 2002.
21. Greba Q, Gifkins A, and Kokkinidis L. Inhibition of amygdaloid dopamine D2 receptors impairs emotional learning measured with fear-potentiated startle. Brain Res 899: 218-226, 2001.
22. Greba Q and Kokkinidis L. Peripheral and intraamygdalar administration of the dopamine D1 receptor antagonist SCH 23390 blocks fear-potentiated startle but not shock reactivity or the shock sensitization of acoustic startle. Behav Neurosci 114: 262-272, 2000.
23. Gulledge AT and Jatfe DB. Multiple effects of dopamine on layer V pyramidal cell excitability in rat prefrontal cortex. J Neurophysiol 86: 586-595, 2001.
24. + current in prefrontal cortical cells. Eur J Neurosci 4: 1087-1092, 1992.
25. Harmer CJ and Phillips GD. Enhanced dopamine efflux in the amygdala by a predictive, but not a non-predictive, stimulus: facilitation by prior repeated D-amphetamine. Neuroscience 90: 119-130, 1999.
26. Häusser M and Clark BA. Tonic synaptic inhibition modulates neuronal output pattern and spatiotemporal synaptic integration. Neuron 19: 665-678, 1997.
27. Henze DA, Gonzalez-Burgos GR, Urban NN, Lewis DA, and Barrionuevo G. Dopamine increases excitability of pyramidal neurons in primate prefrontal cortex. J Neurophysiol 84: 2799-2809, 2000.
28. 2+ conductance. J Neurosci 17: 3334-3342, 1997.
29. + channel regulation of signal propagation in dendrites of hippocampal pyramidal neurons. Nature 387: 869-875, 1997.
30. Hopf FW, Cascini MG, Gordon AS, Diamond I, and Bond A. Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein βγ subunits. J Neurosci 23: 5079-5087, 2003.
31. Hu XT and White FJ. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Synapse 17: 43-61, 1994.
32. Inglis FM and Moghaddam B. Dopaminergic innervation of the amygdala is highly responsive to stress. J Neurochem 72: 1088-1094, 1999.
33. Kebabian JW and Calne DB. Multiple receptors for dopamine. Nature 277: 93-96, 1979.
34. Keefe KA and Gerfen CR. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. Neuroscience 66: 903-913, 1995.
35. Lamont EW and Kokkinidis L. Infusion of the dopamine D1 receptor antagonist SCH 23390 into the amygdala blocks fear expression in a potentiated startle paradigm. Brain Res 795: 128-136, 1998.
36. Lang EJ and Pare D. Synaptic responsiveness of interneurons of the cat lateral amygdaloid nucleus. Neuroscience 83: 877-889, 1998.
37. Leonard SK, Anderson CM, Lachowicz JE, Schulz DW, Kilts CD, and Mailman RB. Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase. Synapse 50: 320-333, 2003.
38. Maltais S, Côte S, Drolet G, and Falardeau P. Cellular colocalization of dopamine D1 mRNA and D2 receptor in rat brain using a D2 dopamine receptor specific polyclonal antibody. Prog Neuropsychopharmacol Biol Psychiatry 24: 1127-1149, 2000.
39. Maren S. Auditory fear conditioning increases CS-elicited spike firing in lateral amygdala neurons even after extensive overtraining. Eur J Neurosci 12: 4047-4054, 2000.
40. McDonald AJ, Muller JF, and Mascagni F. GABAergic innervation of alpha type II calcium/calmodulin-dependent protein kinase immunoreactive pyramidal neurons in the rat basolateral amygdala. J Comp Neurol 446: 199-218, 2002.
41. McGaugh JL. Memory consolidation and the amygdala: a systems perspective. Trends Neurosci 25: 456-461, 2002.
42. Nader K and LeDoux JE. Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations. Behav Neurosci 113: 891-901, 1999.
43. Nisenbaum ES, Xu ZC, and Wilson CJ. Contribution of a slowly inactivating potassium current to the transition to firing of neostriatal spiny projection neurons. J Neurophysiol 71: 1174-1189, 1994.
44. O'Donnell P and Grace AA. Tonic D2-mediated attenuation of cortical excitation in nucleus accumbens neurons recorded in vitro. Brain Res 634: 105-112, 1994.
45. Pare D and Collins DR. Neuronal correlates of fear in the lateral amygdala: multiple extracellular recordings in conscious cats. J Neurosci 20: 2701-2710, 2000.
46. Penit-Soria J, Audinat E, and Crépel F. Excitation of rat prefrontal cortical neurons by dopamine: an in vitro electrophysiological study. Brain Res 425: 263-274, 1987.
47. Quirk GJ, Repa C, and LeDoux JE. Fear conditioning enhances short-latency auditory responses of lateral amygdala neurons: parallel recordings in the freely behaving rat. Neuron 15: 1029-1039, 1995.
48. Rainnie DG, Asprodini EK, and Shinnick-Gallagher P. Intracellular recordings from morphologically identified neurons of the basolateral amygdala. J Neurophysiol 69: 1350-1362, 1993.
49. Rauch SL, Shin LM, and Wright CI. Neuroimaging studies of amygdala function in anxiety disorders. Ann NY Acad Sci 985: 389-410, 2003.
50. Reynolds GP. Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 305: 527-529, 1983.
51. Robbing TW and Everitt BJ. Limbic-striatal memory systems and drug addiction. Neurobiol Learn Mem 78: 625-636, 2002.
52. Rosenkranz JA and Grace AA. Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo. J Neurosci 19: 11027-11039, 1999.
53. Rosenkranz JA and Grace AA. Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. J Neurosci 21: 4090-4103, 2001.
54. Rosenkranz JA and Grace AA. Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. J Neurosci 22: 324-337, 2002a.
55. Rosenkranz JA and Grace AA. Dopamine-mediated modulation of odor-evoked amygdala potentials during pavlovian conditioning. Nature 417: 282-287, 2002b.
56. Sah P. Ca(2+)-activated K+ currents in neurones: types, physiological roles and modulation. Trends Neurosci 19: 150-154, 1996.
57. Scibilia RJ, Lachowicz JE, and Kilts CD. Topographic nonoverlapping distribution of D1 and D2 dopamine receptors in the amygdaloid nuclear complex of the rat brain. Synapse 11: 146-154, 1992.
58. Silvestri S, Seeman MV, Negrete JC, Houle S, Shammi CM, Remington GJ, Kapur S, Zipursky RB, Wilson AA, Christensen BK, and Seeman P. Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharm 152: 174-180, 2000.
59. Spehlmann R and Norcross K. Decreased sensitivity of neurons in the basolateral amygdala to dopamine and noradrenaline iontophoresis after a kindling stimulus. Exp Neurol 83: 204-210, 1984.
60. + current in hippocampal neurons. Nature 336: 379-381, 1988.
61. Surmeier DJ, Bargas J, Hemmings HC, Nairn AC, and Greengard P. Modulation of calcium currents by a D1 dopaminergic protein kinase/ phosphatase cascade in rat neostriatal neurons. Neuron 14: 385-397, 1995.
62. Suzuki T, Ishigooka J, Watanabe S, and Miyaoka H. Enhancement of delayed release of dopamine in the amygdala induced by conditioned fear stress in methamphetamine-sensitized rats. Ear J Pharmacol 435: 59-65. 2002.
63. Volkow ND, Fowler JS, and Wang GJ. Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav Pharmacol 13: 355-366, 2002.
64. Washburn MS and Moises HC. Electrophysiological and morphological properties of rat basolateral amygdaloid neurons in vitro. J Neurosci 12: 4066-4079, 1992.
65. Weiner DM, Levey AI, Sunahara RK, Niznik UB, O'Dowd BF, Seeman P, and Brann MR. D1 and D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci USA 88: 1859-1863, 1991.
66. Yang CR and Seamans JK. Dopamine D1 receptor actions in layers V-VI rat prefrontal cortex neurons in vitro: modulation of dendritic-somatic signal integration. J Neurosci 16: 1922-1935, 1996.